ALKBH5 and pachyonychia congenita: Overexpression of ALKBH5 sensitized PC cells to anticancer drugs and inhibited PC progression by reducing m6A-dependent WNT inhibitory factor 1 (WIF-1) levels and hindering its activation (118).